ArticleBlood advances2025

From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis.

Eli Muchtar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.